Variant report
Variant | nsv521350 |
---|---|
Chromosome Location | chr4:54621715-54629262 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59481386 | chr4:54625401-54625402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs62297702 | chr4:54625406-54625407 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs191621871 | chr4:54625434-54625435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371768917 | chr4:54625454-54625455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567381947 | chr4:54625465-54625466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112939382 | chr4:54625496-54625497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549208807 | chr4:54625533-54625534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115160232 | chr4:54625565-54625566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148613491 | chr4:54625603-54625604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565483873 | chr4:54625649-54625650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10022751 | chr4:54625691-54625692 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs142081570 | chr4:54625705-54625706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557103974 | chr4:54625708-54625709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573723017 | chr4:54625764-54625765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371324637 | chr4:54625830-54625831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557563536 | chr4:54625881-54625882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559928707 | chr4:54625909-54625910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573319196 | chr4:54625910-54625911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs55705508 | chr4:54625974-54625975 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs565191098 | chr4:54625982-54625983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs56061807 | chr4:54625987-54625988 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs550600106 | chr4:54626000-54626001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151142255 | chr4:54626010-54626011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555644562 | chr4:54626016-54626017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185470376 | chr4:54626042-54626043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78856444 | chr4:54626054-54626055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs60086744 | chr4:54626068-54626069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs67780867 | chr4:54626114-54626115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs542259227 | chr4:54626123-54626124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528246085 | chr4:54626177-54626178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141256962 | chr4:54626226-54626227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6842780 | chr4:54626228-54626229 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs562605596 | chr4:54626229-54626230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376065168 | chr4:54626292-54626293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557044566 | chr4:54626300-54626301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531653510 | chr4:54626333-54626334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370044195 | chr4:54626360-54626361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76970740 | chr4:54626409-54626410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12506149 | chr4:54626413-54626414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193262089 | chr4:54626435-54626436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545156818 | chr4:54626449-54626450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558717423 | chr4:54626459-54626460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575578587 | chr4:54626467-54626468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113475277 | chr4:54626579-54626580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112464915 | chr4:54626604-54626605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141704325 | chr4:54626661-54626662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540743406 | chr4:54626692-54626693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560340145 | chr4:54626731-54626732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375775592 | chr4:54626754-54626755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185413983 | chr4:54626765-54626766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164919 | CNVD |
Gastrointestinal stromal cancer | 17527083 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17209131 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:54625400-54626000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:54626000-54629400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr4:54627200-54629400 | Weak transcription | NHLF | lung |
4 | chr4:54629000-54630400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr4:54629200-54630400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr4:54629200-54630400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr4:54629200-54631200 | Enhancers | NHDF-Ad | bronchial |
8 | chr4:54629200-54631800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr4:54629200-54634400 | Enhancers | Muscle Satellite Cultured Cells | -- |